Consort Medical is a leading global contract development and manufacturing organisation (CDMO), providing advanced delivery technologies, formulation and manufacturing solutions for drugs. Their customers include some of the world’s largest pharmaceutical companies. Optimising world-class drug delivery device development and manufacture, together with drug Active Pharmaceutical Ingredient (API) and finished dose formulation and manufacture, within the same Group streamlines and accelerates their pharmaceutical customers’ drug route to market. The Group is at the leading edge of innovation and is committed to investing in patient and customer driven innovation, with the potential to create new treatments, new markets and new opportunities. They also continue to diversify into adjacent complementary markets and technologies which leverage their core competencies in drug formulation, manufacturing and delivery.
Focus Areas
Notable Investments
